MP Anesthesie: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MP Anesthesie
Largest movements
- Receivables within one year +€35,656
up €35,656 (+5.9%), from €601,444 to €637,100
- Reserves +€94,469
up €94,469 (+22.0%), from €428,779 to €523,248
- Other debts -€38,000
no longer reported in 2025 (was €38,000)
- Tax, wage and social debts -€23,619
down €23,619 (-19.1%), from €123,858 to €100,240
- Gross operating margin +€67,136
up €67,136 (+181%), from €37,150 to €104,286
- Taxes +€20,774
up €20,774 (+105%), from €19,767 to €40,541
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €601,643 | €637,214 | +€35,571 | +5.9% |
| Fixed assets | 21/28 | €170 | - | -€170 | |
| Tangible fixed assets | 22/27 | €170 | - | -€170 | |
| Furniture and vehicles | 24 | €170 | - | -€170 | |
| Current assets | 29/58 | €601,472 | €637,214 | +€35,742 | +5.9% |
| Amounts receivable within one year | 40/41 | €601,444 | €637,100 | +€35,656 | +5.9% |
| Other amounts receivable | 41 | €601,444 | €637,100 | +€35,656 | +5.9% |
| Cash at bank and in hand | 54/58 | €28 | €113 | +€86 | +307% |
| Total equity and liabilities | 10/49 | €601,643 | €637,214 | +€35,571 | +5.9% |
| Equity | 10/15 | €433,779 | €528,248 | +€94,469 | +21.8% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €428,779 | €523,248 | +€94,469 | +22.0% |
| Distributable reserves | 133 | €428,779 | €523,248 | +€94,469 | +22.0% |
| Amounts payable | 17/49 | €167,864 | €108,966 | -€58,898 | -35.1% |
| Amounts payable within one year | 42/48 | €166,211 | €105,648 | -€60,563 | -36.4% |
| Financial debts | 43 | - | €2,467 | +€2,467 | |
| Credit institutions | 430/8 | - | €2,467 | +€2,467 | |
| Trade debts | 44 | €4,353 | €2,941 | -€1,412 | -32.4% |
| Suppliers | 440/4 | €4,353 | €2,941 | -€1,412 | -32.4% |
| Taxes, remuneration and social security | 45 | €123,858 | €100,240 | -€23,619 | -19.1% |
| Taxes | 450/3 | €123,858 | €100,240 | -€23,619 | -19.1% |
| Other amounts payable | 47/48 | €38,000 | - | -€38,000 | |
| Accrued charges and deferred income | 492/3 | €1,653 | €3,318 | +€1,665 | +101% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €170 | €170 | +€0 | 0.0% |
| Other operating charges | 640/8 | - | €199 | +€199 | |
| Non-recurring operating charges | 66A | - | €4,690 | +€4,690 | |
| Gross operating margin | 9900 | €37,150 | €104,286 | +€67,136 | +181% |
| Operating profit (loss) | 9901 | €36,979 | €99,226 | +€62,247 | +168% |
| Financial income | 75/76B | €36,091 | €36,809 | +€718 | +2.0% |
| Recurring financial income | 75 | €36,091 | €36,809 | +€718 | +2.0% |
| Financial charges | 65/66B | €960 | €1,025 | +€64 | +6.7% |
| Recurring financial charges | 65 | €960 | €1,025 | +€64 | +6.7% |
| Profit (loss) for the period before taxes | 9903 | €72,110 | €135,010 | +€62,900 | +87.2% |
| Income taxes | 67/77 | €19,767 | €40,541 | +€20,774 | +105% |
| Profit (loss) for the period | 9904 | €52,343 | €94,469 | +€42,126 | +80.5% |
| Profit (loss) for the period to be appropriated | 9905 | €52,343 | €94,469 | +€42,126 | +80.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.